LinkOPH

Mati Therapeutics has been granted a U.S. patent for its nasolacrimal drainage system implants for drug therapy, the company announced in a press release.U.S. patent 8,747,884, entitled “Nasolacrimal Drainage System Implants for Drug Therapy,” covers crucial elements of Mati’s novel punctal plug delivery system for the treatment of ocular indications (PPDS). The design includes mechanisms for retaining the punctal plug in the nasolacrimal system during drug elution, according to the release.

Read more →

The U.S. Food and Drug Administration has approved Ozurdex for the treatment of diabetic macular edema in certain patients, Allergan announced in a press release.The sustained-release, biodegradable dexamethasone intravitreal implant (Ozurdex, Allergan…

Read more →

Real-time optical coherence tomography-guided femtosecond laser technology increased safety and accuracy of the Kamra corneal inlay in patients with history of LASIK, according to a study.“An important advantage is that femtosecond laser pulse can be placed individually at different locations   within the cornea, allowing accurate cuts and adjustment of individual cut patterns, more stable corneal and visual outcomes, and better surgical safety,” the authors wrote in the study.

Read more →